Context: 

Diffuse large B-cell lymphoma (DLBCL), not otherwise specified, stands as the most prevalent aggressive non-Hodgkin lymphoma, characterized by its biological heterogeneity. Despite advancements in immunotherapies, the intricate organization of the DLBCL tumor-immune microenvironment (TIME) remains elusive.

Methodology:

In this study, the researchers meticulously examined the intact TIME of 51 de novo DLBCL cases through triplicate sampling. This comprehensive analysis involved characterizing 337,995 tumor and immune cells using a sophisticated 27-plex antibody panel. This panel enabled them to capture cell lineage, architectural, and functional markers. By spatially assigning individual cells, identifying local cell neighborhoods, and establishing their topographical organization in situ, they discovered that the organization of local tumor and immune cells can be modeled into six composite cell neighborhood types (CNTs).

Results:

Their findings revealed that differential CNT representation categorizes cases into three distinct aggregate TIME categories: immune-deficient, dendritic cell–enriched (DC-enriched), and macrophage-enriched (Mac-enriched).

1. Immune-Deficient TIME: These cases are characterized by tumor cell–rich CNTs with minimal infiltrating immune cells, predominantly located near CD31+ vessels, indicating limited immune activity.
2. DC-Enriched TIME: These cases feature tumor cell–poor/immune cell–rich CNTs with a high presence of CD11c+ dendritic cells and antigen-experienced T cells, also enriched near CD31+ vessels, suggesting heightened immune activity.
3. Mac-Enriched TIME: These cases are marked by tumor cell–poor/immune cell–rich CNTs with a significant number of CD163+ macrophages and CD8 T cells dispersed throughout the microenvironment. This is accompanied by increased IDO-1 and LAG-3 expression and decreased HLA-DR expression, indicative of immune evasion mechanisms.

Implications:

Their research underscores that the heterogeneous cellular components of DLBCL are not randomly distributed but are organized into CNTs that define aggregate TIMEs with distinct cellular, spatial, and functional characteristics. This structured organization of DLBCL cell neighborhoods into immune-deficient, DC-enriched, and macrophage-enriched microenvironments provides crucial insights into the tumor-immune dynamics and could inform future therapeutic strategies.